Rational therapy and modern principles of diagnostics of iron-deficient states in obstetric and gynecological practice


Citar

Texto integral

Resumo

The article details the current state of problem of anemia and iron deficiency anemia (IDA) in obstetrics and gynecology. It has been established that the IDA is the third most common cause of temporary disability among women aged 15-44 years. The data for the epidemiology of IDA, the mechanisms of iron metabolism, etiology of IDA, clinical presentations of the disease, the principles of its diagnosis, prevention and treatment are presented. It is noted that the Ferretab drug, widely used by the authors for the treatment and prevention of IDA in gynecologic patients, conform to modern requirements for iron preparations. The authors consider Ferretab characteristics and application rules.

Bibliografia

  1. Аркадьева Г.В. Диагностика и лечение железодефицитных анемий. М., 1999. 58 с.
  2. Дворецкий Л.И. ЖДА. М., 1998.
  3. Шехтман М.М. В кн.: Экстрагенитальная патология и беременность. М., 1987. С. 143-155.
  4. Ковалева Л. Железодефицитная анемия // Врач. 2002. № 12. С.4-9.
  5. Серов В.Н., Орджоникидзе Н.В. Анемия - акушерские и перинатальные аспекта // РМЖ. 2004. Т. 12. № 1 (201). С. 12-15.
  6. Perewusnyk G, Huch R, Huch A, et al. Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex. Br J Nutr 2002;(88):3-10.
  7. Шеффер Р.М., Гаше К., Хух Р. и др. Железное письмо: рекомендации по лечению железодефицитной анемии // Гематология и трансфузиология. 2004. № 49 (4). С. 40-48.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2009

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies